CHEMTOR, L.P.

Medtech · Private

A fiber reactor platform system for non-dispersive multiphase pharmaceutical synthesis and separation

advancedchemistry.biz →
Grants
$300K
2 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
3
1 granted · 2 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Non-Dispersive Reaction and Separation Processes for Pharmaceutical Synthesis$150,000
Federal grantDepartment of Health and Human Services · Phase I · Non-Dispersive Reaction and Separation Processes for Pharmaceutical Synthesis$150,000
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2218TRULY TECHNOLOGIES LLC——
2219BLOTTING INNOVATIONS, INC——
2220CELESTIAL ONCOLOGY INC.——
2221CHEMTOR, L.P.——
2222XIMIO HEALTH, INC.——
2223Temkin Associates, LLC——
2224CYTOSITE BIOPHARMA, INC.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 1 granted of 3

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.